Investigation of the relationship between MTRR A66G, MTR A2756G gene variations and cell anomalies in early diagnosis and progression of bladder cancer
- PMID: 35715601
- DOI: 10.1007/s11033-022-07597-6
Investigation of the relationship between MTRR A66G, MTR A2756G gene variations and cell anomalies in early diagnosis and progression of bladder cancer
Abstract
Background: The aim of this study is to investigate the relationship between MTRR A66G, MTRA2756G gene variations and cell anomalies in the early diagnosis and progression of bladder cancer.
Methods: PCR and RFLP methods were used to determine the genotype distributions of MTRR A66G and MTR A2756G gene variations. Peripheral smear preparations prepared from blood samples were fixed with methanol fixative and stained histochemically. Cellular morphological evaluations were made under the light microscope.
Results: In our study, AA-GG haplotype was observed significantly more in the patient group than control group (OR: 3.304, 95% CI: 1.023-10.665, p = 0.046). The significant increase was determined in terms of histological damage parameters in the patient group compared to the control group (p < 0.05). For multiple vacuoles damage parameter (mild score), AA genotype of MTR A2756G gene variation was significantly different compared to AA genotype of MTRR A66G gene variation (OR: 0.211, 0.049-0.912, p = 0.037). AA genotype of MTR A2756G gene variation was observed more than AA homozygous genotype of MTR A66G gene variation for giant platelets with different sizes damage parameter (mild score) (OR: 0.062, 0.017-0.228, p < 0.001).
Conclusions: In conclusion, in Thrace population, AA genotype of the MTR A2756G gene variation was significantly higher than the AA homozygous genotype of the MTR A66G gene variation as a genetic risk factor for the multiple vacuoles damage parameter. In addition, AA genotype of MTR A2756G gene variation was determined as a genetic risk factor for giant platelets with different sizes damage parameter.
Keywords: Bladder cancer; Genetic variation; Histological damage parameters; PCR-RFLP; Peripheral smear.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
MTR, MTRR, and MTHFR Gene Polymorphisms and Susceptibility to Nonsyndromic Cleft Lip With or Without Cleft Palate.Genet Test Mol Biomarkers. 2016 Jun;20(6):297-303. doi: 10.1089/gtmb.2015.0186. Epub 2016 May 11. Genet Test Mol Biomarkers. 2016. PMID: 27167580 Free PMC article.
-
Joint associations of folate, homocysteine and MTHFR, MTR and MTRR gene polymorphisms with dyslipidemia in a Chinese hypertensive population: a cross-sectional study.Lipids Health Dis. 2015 Sep 4;14:101. doi: 10.1186/s12944-015-0099-x. Lipids Health Dis. 2015. PMID: 26337056 Free PMC article.
-
Association between MTR A2756G and MTRR A66G polymorphisms and maternal risk for neural tube defects: a meta-analysis.Gene. 2013 Feb 25;515(2):308-12. doi: 10.1016/j.gene.2012.11.070. Epub 2012 Dec 22. Gene. 2013. PMID: 23266814
-
MTHFR C677T、MTHFR A1298C、MTRR A66G and MTR A2756G polymorphisms and male infertility risk: a systematic review and meta-analysis.Reprod Biol Endocrinol. 2024 Oct 30;22(1):133. doi: 10.1186/s12958-024-01306-7. Reprod Biol Endocrinol. 2024. PMID: 39478547 Free PMC article.
-
The Association of MTHFR C677T and MTR A2756G Gene Polymorphisms With the Risk of Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis.J Clin Rheumatol. 2021 Dec 1;27(8):e580-e582. doi: 10.1097/RHU.0000000000001240. J Clin Rheumatol. 2021. PMID: 31868834 No abstract available.
References
-
- Wu C-C, Huang Y-K, Huang C-Y, Shiue H-S, Pu Y-S, Su C-T, Lin Y-C, Hsueh Y-M (2018) Polymorphisms of TNF-α -308 G/A and IL-8 -251 T/A Genes Associated with Urothelial Carcinoma: A Case-Control Study. Biomed Res Int 1–8. https://doi.org/10.1155/2018/3148137
-
- Yan Y, Liang H, Li T, Li M, Li R, Qin X, Li S (2014) The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis. Tumour Biol 35(4):3047–3052. doi: https://doi.org/10.1007/s13277-013-1395-6 - DOI - PubMed
-
- de Maturana EL, Rava M, Anumudu C, Sáez O, Alonso D, Malats N (2018) Bladder Cancer Genetic Susceptibility. Syst Rev Bladder Cancer 4(2):215–226. doi: https://doi.org/10.3233/BLC-170159 - DOI
-
- García-Closas R, García-Closas M, Kogevinas M, Malats N, Silverman D, Serra C, Tardón A, Carrato A, Castaño-Vinyals G, Dosemeci M, Moore L, Rothman N, Sinha R (2007) Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. Eur J Cancer 43(11):1731–1740. doi: https://doi.org/10.1016/j.ejca.2007.05.007 - DOI - PubMed
-
- Goyette P, Pai A, Milos R, Frosst P, Tran P, Chen Z, Chan M, Rozen R (1998) Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 9(8):652–656. doi: https://doi.org/10.1007/s003359900838 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical